DBAZA
Clinically validated patient onboarding platform for managing and reducing the costs of chronic diseases like diabetes. Used by over 400,000 patients..
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
N/A | Seed | ||
| Total Funding | 000k | ||
Related Content
DBAZA Inc., operating as dbaza health, is a digital health company established in the United States in 2014. The firm was co-founded by Sergey Sirotinin, who serves as CEO, and Stefan Tzanev. Sirotinin brings over two decades of experience in scientific research, technology commercialization, and business development to the company's leadership. His background includes serving as a principal investigator on multiple National Institutes of Health (NIH) research projects focused on digital health tools for chronic disease management.
The company focuses on developing solutions for the healthcare and information technology sectors. Its primary offering is a cloud-based platform, referred to as the MLT platform, designed to create and implement targeted interventions for patients. This system utilizes data-driven insights to tailor interventions at an individual level, aiming to address personal barriers to treatment adherence and sustain patient engagement. The platform's goal is to improve health outcomes by fostering healthier lifestyles and behavioral changes. For instance, DBAZA developed a superhero character named Piper to help children better understand and manage their diabetes, which resulted in significant knowledge gains in a clinical trial.
DBAZA's business model targets a clientele that includes Fortune 500 pharmaceutical and medical technology companies, insurers, healthcare systems, and clinical research organizations. The company's platform is designed to help these clients launch digital health products and disseminate interventions to large populations effectively. It provides tools to track the effectiveness of these interventions and optimize delivery pathways to enhance customer experience and loyalty. On July 15, 2015, the company secured seed funding from DreamIt Health, which supported the further development of its cloud platform.
Keywords: digital health, health technology, chronic disease management, patient engagement, behavioral interventions, cloud platform, personalized healthcare, data-driven insights, clinical research tools, adherence solutions, healthcare IT, pharmaceutical technology, medical technology, health interventions, patient activation, diabetes management, NIH research, Sergey Sirotinin, DreamIt Health, MLT platform